Lucira Health to Announce Second Quarter 2021 Financial Results
Lucira Health, a medical technology company, will report its second quarter 2021 financial results on August 12, 2021. The conference call will take place at 1:30 p.m. PT / 4:30 p.m. ET, featuring a discussion on the financial results and a corporate update. Lucira specializes in innovative infectious disease test kits that deliver PCR quality molecular testing using a single-use, consumer-friendly design. Their COVID-19 test kits provide reliable results within 30 minutes, aimed at enhancing accessibility to accurate testing.
- Lucira's COVID-19 test kits deliver PCR quality results in 30 minutes.
- Innovative test design enhances consumer accessibility.
- None.
EMERYVILLE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report second quarter 2021 financial results on, Thursday, August 12, 2021. Lucira’s management will host a conference call and webcast at 1:30 p.m. PT / 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
Conference Call and Webcast Details
The conference call can be accessed by dialing (833) 562-0151 for participants in the U.S. or Canada and (661) 567-1232 for international callers, using conference ID 4241018. A live and archived webcast of the event can be accessed through the following link ir.lucirahealth.com.
About Lucira Health, Inc.
Lucira is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira’s testing platform produces PCR quality molecular testing in a single-use, consumer-friendly, palm-size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular test results anywhere and at any time. The LUCIRA™ CHECK IT COVID-19 Test Kit (OTC) and LUCIRA™ COVID-19 All-In-One Test Kit (Rx) provide PCR quality clinically relevant COVID-19 result within 30 minutes from sample collection. Lucira’s CHECK IT (OTC) also provides a SMS verified digital LUCI PASS test result back to a user’s phone for work, travel and other places where negative test verification may be required.
Investor Contact
Greg Chodaczek
Investorrelations@lucirahealth.com
347-620-7010
Media Contact
Kevin Knight
media@lucirahealth.com
206-451-4823
FAQ
When will Lucira Health report its second quarter 2021 financial results?
What time is the Lucira Health conference call for Q2 2021 results?
What type of testing does Lucira Health specialize in?
How quickly can Lucira's COVID-19 test kits provide results?